Jefferies Starts Minerva Neurosciences (NERV) at Buy

Go back to Jefferies Starts Minerva Neurosciences (NERV) at Buy

JMP Securities Starts Minerva Neurosciences (NERV) at Market Outperform

July 28, 2014 8:04 AM UTC

JMP Securities initiated coverage on Minerva Neurosciences (NASDAQ: NERV) with a Market Outperform rating and a price target of $16.00.

For an analyst ratings summary and ratings history on Minerva Neurosciences click here. For more ratings news on Minerva Neurosciences click here.

Shares of Minerva Neurosciences closed at $6.78 yesterday.

... More

Baird Starts Minerva Neurosciences (NERV) at Outperform

July 28, 2014 7:31 AM UTC

Baird initiates coverage on Minerva Neurosciences (NASDAQ: NERV) with a Outperform rating and a price target of $11.00.

Analyst Brian Skorney comments, "several shots on goal make Minerva an interesting opportunity, initiating at Outperform with an $11 price target. Despite the high inherent risk associated... More